Development
Bruker Corporation
BRKR
$34.54
$2.186.74%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 16.87% | 12.27% | 9.50% | 6.56% | 4.67% |
| Total Other Revenue | 47.66% | 36.92% | 53.73% | 76.47% | 44.59% |
| Total Revenue | 17.14% | 12.48% | 9.64% | 6.62% | 4.67% |
| Cost of Revenue | 18.10% | 12.08% | 7.89% | 3.53% | 1.63% |
| Gross Profit | 16.24% | 12.85% | 11.33% | 9.66% | 7.68% |
| SG&A Expenses | 17.29% | 12.31% | 9.49% | 10.34% | 10.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 338.18% | 286.05% | -127.27% | -198.21% | -241.03% |
| Total Operating Expenses | 19.58% | 13.57% | 9.04% | 5.80% | 4.12% |
| Operating Income | 6.05% | 7.46% | 12.48% | 10.45% | 7.24% |
| Income Before Tax | 31.65% | 3.27% | 11.33% | 6.44% | 5.41% |
| Income Tax Expenses | 1.12% | -23.81% | -1.38% | -2.56% | 3.01% |
| Earnings from Continuing Operations | 43.55% | 16.65% | 16.67% | 10.14% | 6.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 31.58% | -138.46% | -40.00% | 20.69% | 45.71% |
| Net Income | 44.03% | 16.08% | 16.50% | 10.46% | 7.04% |
| EBIT | 6.05% | 7.46% | 12.48% | 10.45% | 7.24% |
| EBITDA | 9.85% | 9.00% | 11.89% | 9.39% | 5.92% |
| EPS Basic | 46.18% | 18.22% | 19.31% | 13.16% | 9.30% |
| Normalized Basic EPS | 11.92% | 7.43% | 15.28% | 12.55% | 11.12% |
| EPS Diluted | 46.48% | 19.29% | 20.06% | 13.63% | 10.01% |
| Normalized Diluted EPS | 12.02% | 7.54% | 15.51% | 12.89% | 11.49% |
| Average Basic Shares Outstanding | -1.45% | -1.87% | -2.26% | -2.27% | -1.90% |
| Average Diluted Shares Outstanding | -1.52% | -1.96% | -2.42% | -2.58% | -2.24% |
| Dividend Per Share | 0.00% | 5.26% | 11.11% | 17.65% | 25.00% |
| Payout Ratio | -0.32% | -0.11% | -0.07% | 0.05% | 0.15% |